Tarcocimab and Tabirafusp for Wet Age-Related Macular Degeneration

Tarcocimab and Tabirafusp for Wet Age-Related Macular Degeneration
82%71%60%May 18May 19May 20May 21May 22May 23May 24May 25May 26May 27May 27 • YES 71.4%
Kodiak Sciences Inc ($KOD)
No stock close$37.89$35.92$33.94May 18May 19May 20May 21May 22May 23May 24May 25May 26May 27May 18 • KOD $35.02May 19 • KOD $34.42May 20 • KOD $36.22May 21 • KOD $37.41May 22 • KOD $36.23May 26 • KOD $36.00May 27 • KOD $35.09

Will this trial show a positive result on best corrected visual acuity (BCVA), Mean change in BCVA from Day 1 to Year 1, Week 48?

Paper Trading
Create account to trade
No oracle findings have been stored for this trial yet.
Stats
Latest Run
No runs yet
Model
No runs yet
Runs
0 runs